» Articles » PMID: 19581493

Trends in Cardiovascular Disease Risk Factors in Individuals with and Without Diabetes Mellitus in the Framingham Heart Study

Overview
Journal Circulation
Date 2009 Jul 8
PMID 19581493
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Individuals with diabetes mellitus are at 2- to 3-fold increased risk for cardiovascular disease (CVD) relative to those without diabetes. Our objective was to examine CVD risk factor level changes among individuals with and without type 2 diabetes mellitus from 1970 to 2005 in the Framingham Heart Study.

Methods And Results: We included 4195 participants (3990 with no diabetes and 205 with diabetes) 50 years of age and 3495 participants (3178 with no diabetes and 317 with diabetes) 60 years of age. Contemporaneous CVD risk factor levels were measured; linear regression models were used to assess the interaction between diabetes status and calendar year on CVD risk factor levels. Among 50-year-olds without diabetes mellitus, there was an increase in body mass index of 0.39 kg/m(2) per 10 years, whereas for those with diabetes, there was an increase of 2.52 kg/m(2) (P value for the diabetes-by-calendar year interaction [P for interaction] <0.001). For low-density lipoprotein cholesterol, the mean decrease was -7.43 mg/dL per decade (nondiabetes) and -15.5 mg/dL for diabetes (P for interaction=0.002). For systolic blood pressure, the mean decrease was -3.35 mm Hg per decade (nondiabetes) and -3.50 mm Hg for diabetes (P for interaction=0.97). The direction of the trends for those with diabetes relative to those without diabetes was similar for 60-year-olds.

Conclusions: Compared with individuals without diabetes mellitus, individuals with diabetes experienced a greater increase in body mass index, a greater decrease in low-density lipoprotein cholesterol, and a similar magnitude of decline in systolic blood pressure. Individuals with diabetes mellitus have not experienced the necessary declines in CVD risk factors to overcome their increased risk of CVD. Further efforts are needed to aggressively control CVD risk factors among individuals with diabetes mellitus.

Citing Articles

Surrogate markers of insulin resistance and coronary artery disease in type 2 diabetes: U-shaped TyG association and insights from machine learning integration.

Yadegar A, Mohammadi F, Seifouri K, Mokhtarpour K, Yadegar S, Bahrami Hazaveh E Lipids Health Dis. 2025; 24(1):96.

PMID: 40089748 DOI: 10.1186/s12944-025-02526-5.


Sex-specific differences in the relationship between fasting plasma glucose and carotid plaque in a cardiovascular high-risk population: a cross-sectional study.

Xu M, Xu K, Lin W, Sun R, Yan S, Chen X Front Endocrinol (Lausanne). 2025; 16:1478640.

PMID: 40046880 PMC: 11880609. DOI: 10.3389/fendo.2025.1478640.


[Colchicine-Phoenix from the ashes].

Lunzer R, Delle-Karth G, Zeitlinger M, Prager M, Pracher L Wien Klin Wochenschr. 2025; 137(Suppl 1):1-33.

PMID: 39912853 PMC: 11802715. DOI: 10.1007/s00508-024-02490-7.


Mechanistic insights and therapeutic potential of astilbin and apigenin in diabetic cardiomyopathy.

Dhiman S, Dhankhar S, Garg A, Rohilla M, Saini M, Singh T Heliyon. 2024; 10(21):e39996.

PMID: 39583813 PMC: 11582444. DOI: 10.1016/j.heliyon.2024.e39996.


Social Determinants of Health and Cardiovascular Risk among Adults with Diabetes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Zhang L, Reshetnyak E, Ringel J, Pinheiro L, Carson A, Cummings D Diabetes Metab J. 2024; 48(6):1073-1083.

PMID: 39034653 PMC: 11621655. DOI: 10.4093/dmj.2023.0380.


References
1.
Kannel W, Feinleib M, MCNAMARA P, Garrison R, CASTELLI W . An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol. 1979; 110(3):281-90. DOI: 10.1093/oxfordjournals.aje.a112813. View

2.
DAWBER T, Kannel W, LYELL L . An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci. 1963; 107:539-56. DOI: 10.1111/j.1749-6632.1963.tb13299.x. View

3.
Hansson L, Zanchetti A, Carruthers S, Dahlof B, Elmfeldt D, Julius S . Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998; 351(9118):1755-62. DOI: 10.1016/s0140-6736(98)04311-6. View

4.
LaRosa J, Grundy S, Waters D, Shear C, Barter P, Fruchart J . Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005; 352(14):1425-35. DOI: 10.1056/NEJMoa050461. View

5.
Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart J, Haffner S . Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care. 2006; 29(6):1220-6. DOI: 10.2337/dc05-2465. View